AMGN SEC Filing News — Amgen Inc.

Latest SEC filings for Amgen Inc. (AMGN) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). All data sourced directly from SEC EDGAR — last updated 2026-07-31.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of my…
Sector: Healthcare Industry: Drug Manufacturers - General Market Cap: $207.9B CIK: 318154
20
Total Filings
0
Bullish Signals
0
Bearish Signals
17
Insider Transactions
3
Material Events (8-K)
0
Periodic Reports
What you're looking at: Each item below is parsed from an actual SEC filing submitted by Amgen Inc.. Form 4 = confirmed insider transaction · Form 144 = proposed sale notice · 8-K = material event (earnings, M&A, leadership change, etc.) · 10-Q / 10-K = quarterly / annual report.
AMGN Filing Activity Snapshot 2026-05-11 — 2026-07-31
Insider Transactions (Form 4)
0 buys vs 0 sells
Insider buying and selling activity is balanced in this period.
Recent SEC Filings
Form 8-K Material Company Update 2026-07-31

AMGN filed 8-K — material company event

AMGEN INC filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

MILES AMY E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: MILES AMY E (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Kullman Ellen Jamison (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Kullman Ellen Jamison (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Klotman Mary E. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Klotman Mary E. (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Jacks Tyler (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Jacks Tyler (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

ISHRAK OMAR (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: ISHRAK OMAR (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

HOLLEY CHARLES M (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: HOLLEY CHARLES M (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Garland Greg C. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Garland Greg C. (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

ECKERT ROBERT (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: ECKERT ROBERT (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Druker Brian (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Druker Brian (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Drake Michael V (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Drake Michael V (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-21

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Austin Wanda M (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Austin Wanda M (Director) Shares: 665
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-05-20

AMGN filed 8-K — material company event

AMGEN INC filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-05-19

AMGN filed 8-K — material company event

AMGEN INC filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-11

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Busch Matthew C. (VP, Finance & CAO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Busch Matthew C. (VP, Finance & CAO) Shares: 41
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-11

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Santos Esteban (EVP, Operations) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Santos Esteban (EVP, Operations) Shares: 522
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-11

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

REESE DAVID M (EVP & Chief Technology Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: REESE DAVID M (EVP & Chief Technology Officer) Shares: 556
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-11

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Miller Derek (SVP, Human Resources) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Miller Derek (SVP, Human Resources) Shares: 151
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-11

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Khosla Rachna (SVP, Business Development) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Khosla Rachna (SVP, Business Development) Shares: 93
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-11

AMGN insider Form 4 filed for equity award, exercise, or tax withholding

Grygiel Nancy A. (SVP & CCO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Grygiel Nancy A. (SVP & CCO) Shares: 88
View on SEC EDGAR → Open Filing Document →

Understanding Amgen Inc.'s SEC Filings

Form 4 — Insider Transactions

Executives, directors, and large shareholders must report any purchase or sale of AMGN shares within two business days. Consistent buying by multiple insiders is often read as a confidence signal; large sales may reflect diversification or liquidity needs rather than negative conviction.

Form 144 — Proposed Insider Sales

Filed when a company affiliate intends to sell restricted or control shares. A Form 144 is a notice of intent, not confirmation — the actual sale is later confirmed via Form 4. It gives investors advance visibility into planned insider selling activity.

8-K — Material Events

The 8-K is an event-driven filing that Amgen Inc. must submit within four business days of a significant development — including earnings results, mergers, executive changes, credit facility updates, or regulatory actions. Each 8-K item code maps to a specific event type.

10-Q & 10-K — Periodic Reports

The 10-Q (quarterly) and 10-K (annual) are comprehensive reports covering Amgen Inc.'s financial results, risk factors, management discussion, and business operations. The 10-K includes audited financials and is the most complete public disclosure the company makes each year.

Frequently Asked Questions — AMGN SEC Filings

What SEC filings does Amgen Inc. submit to the SEC?

Amgen Inc. (AMGN) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about AMGN?

A Form 4 for AMGN discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the date, number of shares bought or sold, the price, and the insider's updated total ownership. Consistent insider buying across multiple executives is often interpreted as a bullish signal.

How do I interpret an 8-K filing from Amgen Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for AMGN?

The 10-K is Amgen Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all AMGN SEC filings directly on EDGAR?

You can view all historical Amgen Inc. filings on the SEC EDGAR company page for AMGN. Each filing card on this page links directly to the original SEC document.

How often does Amgen Inc. file with the SEC?

Amgen Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling AMGN shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

More Tools for AMGN

AMGN Full Stock Analysis AMGN Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Demand Zone Analyzer Sector Scanner Browse All Stocks

Want deeper AMGN analysis?

View valuation, growth metrics, AI Strong Buy score, demand zones, peer comparison, and more — all on the AMGN stock analysis page.

AMGN Full Analysis
SEC filing data is sourced from SEC EDGAR. This page is updated automatically as new filings are detected. Content is for informational purposes only and does not constitute investment advice. Full Disclaimer.